NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/03/2026
Back to search
Official data from USPTO
BAP PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BAP PHARMA
ST13
US500000098721885Class
35, 39, 42
Filing
98721885
Registration
8123138
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
02/04/2026
Trademark type
Word
Nice classes
35, 39, 42
Filing date
08/28/2024
Registration date
02/03/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/03/2026
Last transaction
02/04/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
24
Owner location
Buckinghamshire, GB
Examiner
DONEGAN,DANIEL P
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BAP Pharma Limited
Representatives
Alison M. Caless Cantor Colburn LLP
Technical classification
Nice Classes
Class 35Class 39Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business advisory services; business advisory services relating to supply chain management and the sourcing and procurement of goods and services; business advisory services relating to the manufacturemarketing and sale of pharmaceutical products; business advisory services relating to the operation of clinical trials; business advisory and support services in the nature of consulting concerning marketing authorisations and approvals for pharmaceutical products; business advisory services relating to the provision of bespoke medicines access programs; providing outsourcing services for the procurement and business management of randomisation lists in clinical trialsfor business and commercial purposes; business consultancy services; distributorship services in the field of pharmaceutical products and medical and scientific equipment for use in clinical trials.
Class 39
Storage and transportation services for pharmaceutical products; packaging services for pharmaceutical products; packaging of pharmaceutical products; re-packaging services for pharmaceutical products; re-packaging of pharmaceutical products; product labelling services for the merchandise of others; cold chain storage and transportation services for pharmaceutical products; cold chain storage and transportation of pharmaceutical products; cold chain storage and transportation of medical and scientific equipment
Class 42
Conducting clinical trials for others in the field of pharmaceutical products; new product design services; designing and planning clinical trials; packaging design services; design of medical and pharmaceutical product information booklets and leaflets; quality control services for others; quality management services in the nature of quality control services for others; quality management services in the nature of inspection of imported medicinal products for quality control purposes; informationadvisory and consultancy services relating to the aforesaid.
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/16/2025
PUBO
PUBLISHED FOR OPPOSITION
12/16/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/19/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
11/19/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/19/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
11/19/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/19/2025
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/06/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/23/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/02/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
09/02/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/02/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
09/02/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/04/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/05/2025
GNRT
NON-FINAL ACTION E-MAILED
03/05/2025
CNRT
NON-FINAL ACTION WRITTEN
03/05/2025
DOCK
ASSIGNED TO EXAMINER
03/04/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/17/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/09/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/09/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/09/2024
NWAP
NEW APPLICATION ENTERED
08/28/2024
Continuous trademark protection
Get notified about every new filing that threatens BAP PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.